Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 1

Status

Completed 3

Sponsor Class

OTHER 45NIH 3OTHER_GOV 2INDUSTRY 2FED 1

Study Type

Interventional 3

Sponsor

Conditions

Polycystic Ovary Syndrome 3Rare Diseases 2Hyperinsulinism 2Endocrine System Diseases 2Infertility 1

Interventions

Cyclophosphamide 385Specimen Handling 371Magnetic Resonance Spectroscopy 325Radiotherapy 306Biopsy 269Cisplatin 257Carboplatin 253Paclitaxel 235Doxorubicin 226Fluorouracil 200Etoposide 197Vincristine 182Bevacizumab 180Filgrastim 170Gemcitabine 163Leucovorin 149Cytarabine 144aldesleukin 140Taxes 127Docetaxel 122Oxaliplatin 113Chemotherapy, Adjuvant 113fludarabine phosphate 111Rituximab 107Methotrexate 107Radiation 106Bortezomib 105Prednisone 102Irinotecan 100Dexamethasone 100

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
NIH × Interventional × Clomiphene × Clear all
NCT00068861 2007-10-01

Treatment of Infertility in Women With Polycystic Ovary Syndrome

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Phase 3 Completed
678 enrolled

Infertility, Polycystic Ovary Syndrome

NCT00005104 2005-06-24

Randomized Study of Decreased Hyperinsulinemia on the Ovulatory Response to Clomiphene Citrate in Women With Polycystic Ovary Syndrome

National Center for Research Resources (NCRR)

Phase NA Completed
99 enrolled

Endocrine System Diseases, Hyperinsulinism, Polycystic Ovary Syndrome, Rare Diseases

NCT00005654 2005-06-24

Randomized Study of the Effect of Decreased Hyperinsulinemia on the Ovulatory Response to Clomiphene Citrate in Obese Women With Polycystic Ovary Syndrome

Office of Rare Diseases (ORD)

Phase NA Completed
88 enrolled

Endocrine System Diseases, Hyperinsulinism, Polycystic Ovary Syndrome, Rare Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡